Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom
With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.
Get All the Details on #1 Stock

IPSC Insider Trading (Century Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $15,000,000.00
Insider Selling (Last 12 Months): $0.00

Century Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Century Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Century Therapeutics Share Price & Price History

Current Price: $16.99
Price Change: Price Decrease of -0.21 (-1.22%)
As of 11/29/2021 01:37 PM ET

This chart shows the closing price history over time for IPSC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
635% Growth For American Lithium Company After They Fight Back Against China
The USA is fighting an economic war with China over lithium. Until now, we've been losing (with China controlling 80% of lithium production). But this small lithium company could change that with their significant holdings in the hottest area of the US for lithium discoveries.
They've Already Seen 635% Growth In 2021

Century Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/22/2021Eli CasdinDirectorBuy750,000$20.00$15,000,000.00
See Full Table
Insider Buying at Century Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Century Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Century Therapeutics (NASDAQ:IPSC)

35.23% of Century Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IPSC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Century Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2021American International Group Inc.6,463$0.16M0.0%N/A0.012%Search for SEC Filing on Google Icon
11/18/2021Bank of New York Mellon Corp28,932$0.73M0.0%N/A0.053%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC13,600$0.34M0.0%-24.9%0.025%Search for SEC Filing on Google Icon
11/16/2021Metropolitan Life Insurance Co NY3,737$94K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC69,024$1.74M0.0%-61.9%0.127%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC24,044$0.61M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System6,381$0.16M0.0%N/A0.012%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP111,552$2.81M0.0%+111.5%0.205%Search for SEC Filing on Google Icon
11/15/2021Royal Bank of Canada1,399$35K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley331,869$8.35M0.0%-1.3%0.610%Search for SEC Filing on Google Icon
11/12/2021Ghisallo Capital Management LLC15,000$0.38M0.0%-50.0%0.028%Search for SEC Filing on Google Icon
11/12/2021Parametrica Management Ltd28,755$0.72M0.5%N/A0.053%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC204,691$5.15M0.0%+429.4%0.376%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.1,335$34K0.0%N/A0.002%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.648,656$16.32M0.0%N/A1.192%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG6,795$0.17M0.0%N/A0.012%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund2,100$53K0.0%N/A0.004%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC5,314$0.13M0.0%N/A0.010%Search for SEC Filing on Google Icon
10/22/2021Strs Ohio2,700$67K0.0%N/A0.005%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP52,749$1.55M0.0%N/A0.097%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace North America L.P.247,251$7.25M0.0%N/A0.454%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley336,223$9.87M0.0%N/A0.618%Search for SEC Filing on Google Icon
8/17/2021Woodline Partners LP281,726$8.27M0.2%N/A0.514%Search for SEC Filing on Google Icon
8/17/2021Sphera Funds Management LTD.80,000$2.35M0.2%N/A0.146%Search for SEC Filing on Google Icon
8/17/2021Logos Global Management LP989,095$29.02M2.5%N/A1.804%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC181,164$5.32M0.0%N/A0.330%Search for SEC Filing on Google Icon
8/17/2021Octagon Capital Advisors LP403,523$11.84M2.5%N/A0.736%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP30,000$0.88M0.0%N/A0.055%Search for SEC Filing on Google Icon
8/16/2021LMR Partners LLP49,323$1.45M0.0%N/A0.090%Search for SEC Filing on Google Icon
8/16/2021Hhlr Advisors LTD.614,095$18.02M0.2%N/A1.120%Search for SEC Filing on Google Icon
8/16/2021RA Capital Management L.P.914,094$26.82M0.4%N/A1.667%Search for SEC Filing on Google Icon
8/16/2021Tudor Investment Corp Et Al7,000$0.21M0.0%N/A0.013%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley336,223$9.87M0.0%N/A0.613%Search for SEC Filing on Google Icon
8/16/2021Schonfeld Strategic Advisors LLC18,100$0.53M0.0%N/A0.033%Search for SEC Filing on Google Icon
8/16/2021Pinz Capital Management LP38,500$1.13M0.3%N/A0.070%Search for SEC Filing on Google Icon
8/16/2021Maven Securities LTD48,483$1.45M0.1%N/A0.088%Search for SEC Filing on Google Icon
8/16/2021Federated Hermes Inc.550,000$16.14M0.0%N/A1.003%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.52,808$1.55M0.0%N/A0.096%Search for SEC Filing on Google Icon
8/13/2021Qube Research & Technologies Ltd19,979$0.59M0.0%N/A0.036%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC38,668$1.13M0.0%N/A0.071%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.30,000$0.88M0.0%N/A0.055%Search for SEC Filing on Google Icon
8/13/2021FMR LLC4,959,411$141M0.0%N/A9.046%Search for SEC Filing on Google Icon
8/12/2021Legal & General Group Plc1,000$29K0.0%N/A0.002%Search for SEC Filing on Google Icon
8/12/2021Monashee Investment Management LLC60,000$1.76M0.2%N/A0.109%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Century Therapeutics logo
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT or CAR-iNK candidate targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; and CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia. The company was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.
Read More on Century Therapeutics

Today's Range

Now: $16.99
Low: $16.73
High: $17.40

50 Day Range

MA: $21.96
Low: $16.36
High: $29.25

52 Week Range

Now: $16.99
Low: $16.29
High: $32.90

Volume

863 shs

Average Volume

178,424 shs

Market Capitalization

$928.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Century Therapeutics?

Century Therapeutics' top insider investors include:
  1. Eli Casdin (Director)
  2. Versant Venture Capital Vi, L (Major Shareholder)

Who are the major institutional investors of Century Therapeutics?

Century Therapeutics' top institutional investors include:
  1. BlackRock Inc. — 1.19%
  2. Morgan Stanley — 0.61%
  3. Geode Capital Management LLC — 0.38%
  4. Marshall Wace LLP — 0.21%
  5. Millennium Management LLC — 0.13%
  6. Bank of New York Mellon Corp — 0.05%

Which institutional investors are selling Century Therapeutics stock?

During the previous quarter, IPSC stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Ghisallo Capital Management LLC
  3. Schonfeld Strategic Advisors LLC
  4. Morgan Stanley

Which institutional investors are buying Century Therapeutics stock?

Within the last quarter, IPSC stock was acquired by institutional investors including:
  1. BlackRock Inc.
  2. Geode Capital Management LLC
  3. Marshall Wace LLP
  4. Bank of New York Mellon Corp
  5. Parametrica Management Ltd
  6. Citadel Advisors LLC
  7. Deutsche Bank AG
  8. American International Group Inc.
During the previous year, these company insiders have bought Century Therapeutics stock:
  1. Eli Casdin (Director)
  2. Versant Venture Capital Vi, L (Major Shareholder)
Biden Warns: China Could "Eat Our Lunch" When it Comes to Lithium
Pres. Biden recently warned about China's dominance when it comes to lithium demand, stating, "if we don't get moving, they're going to eat our lunch." One junior mining company in South America is looking to become a strong link in the lithium supply chain due to a monster acquisition.
Get the full scoop on this investment opportunity